Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03686046 · ClinicalTrials.gov registry record
Evaluation of an Open-source Speech-processing Platform
A clinical trial, sponsored by San Diego State University.
- Completed
- Registry status
- 22
- Enrollment target
NCT03686046: Completed study, sponsored by San Diego State University.
NCT03686046 is a clinical trial that has completed, run by San Diego State University. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03686046 has completed, sponsored by San Diego State University.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
Determining acceptability and usability of a wearable open-source speech processing platform (Master Hearing Aid) developed for hearing-aid research
Primary Outcome
5-point rating scale. 5 = definitely would use. 0 = definitely would not use
Interventions
- OTHER Exploratory use
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2019-05-10 |
| Est. Completion | 2020-05-15 |
What the finished NCT03686046 record still lists
NCT03686046 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Exploratory use is the first listed.
NCT03686046 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03686046 about?
NCT03686046 is a clinical study titled "Evaluation of an Open-source Speech-processing Platform". Determining acceptability and usability of a wearable open-source speech processing platform (Master Hearing Aid) developed for hearing-aid research
What is the current status of trial NCT03686046?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2019-05-10. Estimated completion is 2020-05-15.
What interventions are being tested in trial NCT03686046?
The interventions under investigation include: Exploratory use (OTHER).
Who is sponsoring clinical trial NCT03686046?
This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI